IGC Pharma, Inc. Common Stock (NY:IGC)

0.2749 +0.0049 (+1.81%)

Official Closing Price Updated: 8:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry

December 07, 2022

Via CannabisNewsWire

Topics Cannabis

BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms

December 02, 2022

Via Investor Brand Network

BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) to Present at RHK 2022 Disruptive Growth Conference

December 01, 2022

Via Investor Brand Network

The Future Of The Indian Market ↗

June 19, 2022

India has an estimated 26,000 startups, making it the third-largest startup ecosystem in the world, recording consolidated inflows of over $36 billion in the past 3 years.

Via Talk Markets

IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease ↗

December 01, 2022

India Globalization Capital, Inc. (AMEX:IGC) has begun “A phase 2, multi-center, double-blind, randomized, placebo-controlled, trial of the safety and efficacy of IGC-AD1 on agitation in participants...

Via Benzinga

IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease

December 01, 2022

From India Globalization Capital, Inc.

Via Business Wire

InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Numbers for Q2

November 02, 2022

Via Investor Brand Network

Topics Intellectual Property

India Globalization Capital Inc. (NYSE American: IGC) Is ‘One to Watch’

November 02, 2022

Via Investor Brand Network

Topics Intellectual Property

IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials ↗

November 02, 2022

India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022.

Via Benzinga

IGC Reports Financial Results for Second Fiscal Quarter Ended Sept. 30, 2022

November 01, 2022

From India Globalization Capital, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

Via InvestorPlace

IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC ↗

September 21, 2022

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme...

Via Benzinga

IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC

September 21, 2022

From India Globalization Capital, Inc.

Via Business Wire

IGC Announces Results of its 2022 Annual Stockholders Meeting

September 12, 2022

From India Globalization Capital, Inc.

Via Business Wire

IGC Stock Slightly Up On Q1 2023 Revenue Growth Of 175%, What About Gross Profit? ↗

August 08, 2022

India Globalization Capital, Inc. (AMEX:IGC) revenue in Q1 2023 was approximately $212,000 an increase of 175% compared to $77,000 in the same quarter of 2022.

Via Benzinga

IGC Reports Financial Results for the Quarter Ended June 30, 2022

August 08, 2022

From India Globalization Capital, Inc.

Via Business Wire

IGC Revenue Drops 55.8% In Fiscal 2022, What About Gross Profit? ↗

June 23, 2022

India Globalization Capital, Inc. (AMEX:IGC) revenue in fiscal 2022 was $397,000, a 55.8% decrease compared to $898,000 in fiscal 2021.

Via Benzinga

IGC Reports Financial Results for Fiscal Year Ended March 31, 2022

June 22, 2022

From India Globalization Capital, Inc.

Via Business Wire

IGC Acquires Exclusive Rights For A Potential Alzheimer's Drug Development Candidate ↗

June 21, 2022

One of subsidiaries of India Globalization Capital, Inc. (NYSE: IGC) reached an intellectual property license agreement for a potential Alzheimer’s drug development candidate.

Via Benzinga

IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate

June 21, 2022

From India Globalization Capital, Inc.

Via Business Wire

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

44 Stocks Moving In Friday's Mid-Day Session ↗

June 10, 2022

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

June 09, 2022

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.

Via Benzinga

69 Biggest Movers From Yesterday ↗

June 10, 2022

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.

Via Benzinga

IGC Receives U.S. Patent For Method And Composition For Treating Seizure Disorders, Utilizing CBD ↗

June 09, 2022

United States Patent and Trademark Office issued a patent (#11,351,152) to the India Globalization Capital, Inc. (AMEX:IGC) titled “Method and Composition for Treating Seizure Disorders.”

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 09, 2022

Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

18 Stocks Moving in Thursday's Pre-Market Session ↗

June 09, 2022

Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.

Via Benzinga

IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders

June 08, 2022

From India Globalization Capital, Inc.

Via Business Wire

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 03, 2022

Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.